NCT07203859 The Effectiveness of Quadro İliac Plane Block in Percutaneous Nephrolithotomies
| NCT ID | NCT07203859 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cumhuriyet University |
| Condition | Postoperative Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-09-25 |
| Primary Completion | 2026-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-09-25 with a primary completion date of 2026-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Our aim was to investigate the effect of quadro iliac plane block on postoperative analgesia in patients undergoing percutaneous nephrolithotomy surgery and to determine which areas of the skin this block anesthetizes.
Eligibility Criteria
Inclusion Criteria: * Adult patients over 18 years of age who underwent percutaneous nephrolithotomy under general anesthesia and were I-II-III according to the American Society of Anesthesiologists (ASA) risk classification were included in the study. Exclusion Criteria: * patients who did not give consent, * patients with coagulopathy, * patients with signs of infection at the block application site, * patients using anticoagulants, * patients with known allergies to any of the study drugs, * patients with unstable hemodynamics, * patients who could not cooperate during postoperative pain assessment * patients who wanted to withdraw from the study, * patients with alcohol and drug addiction, * patients with musculoskeletal abnormalities
Contact & Investigator
OĞUZ GÜNDOĞDU
PRINCIPAL INVESTIGATOR
Sivas Cumhuriyet University School of Medicine, Anesthesiology and Reanimation
Frequently Asked Questions
Who can join the NCT07203859 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Postoperative Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07203859 currently recruiting?
Yes, NCT07203859 is actively recruiting participants. Contact the research team at droguzgundogdu@gmail.com for enrollment information.
Where is the NCT07203859 trial being conducted?
This trial is being conducted at Sivas, Turkey (Türkiye).
Who is sponsoring the NCT07203859 clinical trial?
NCT07203859 is sponsored by Cumhuriyet University. The principal investigator is OĞUZ GÜNDOĞDU at Sivas Cumhuriyet University School of Medicine, Anesthesiology and Reanimation. The trial plans to enroll 60 participants.